✦ LIBER ✦

NSCLC: Dose escalation by target splitting with asymmetric collimation

✍ Scribed by K. Wurstbauer; H. Deutschmann; M. Kranzinger; F. Merz; H. Rahim; F. Sedlmayer; H.D. Kogelnik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non–Small-Cell Lung Cancer: Dose Escalat

✍ Karl Wurstbauer; Heinz Deutschmann; Felix Sedlmayer; H. Dieter Kogelnik 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 112 KB

Inoperable NSCLC: Preliminary results of

✍ Wurstbauer, K; Deutschmann, H; Kopp, P; Kranzinger, M; Merz, F; Rahim, H; Sedlma 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

P-181 NSCLC in advanced stages: Radiothe

✍ Wurstbauer, Karl; Deutschmann, Heinz; Kopp, Peter; Kranzinger, Manfred; Merz, Fl 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

NSCLC: Primary Tumor Size – Radiation Do

✍ Karl Wurstbauer; Heinz Deutschmann; Peter Kopp; Manfred Kranzinger; Florian Merz 📂 Article 📅 2007 🏛 Springer 🌐 German ⚖ 247 KB

784 Increased tumor control probability

✍ A. van der Wel; S. Nijsten; S. Bentzen; M. Hochstenbag; U. Bull; L. Lutgens; R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Phase I Trial of Escalated Doses of Targ

✍ A.S. Stein; J. Wong; M.R. O'Donnell; D.S. Synder; J.M. Palmer; N.-C. Tsai; P. Pa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 76 KB